Thursday, December 30, 2004 8:53:24 PM
It costs an average of $900 Million to develop a new drug. It is obviously 'more profitable' to reincarnate previously developed drugs than to start over with new drugs.
You are correct, the guidance hasn't prevented anyone from developing classifiers, and all those classifiers are just waiting for the 'forms' and the rules for the approval process.
The 'reason' the FDA is developing the guidelines is that the industry has a number of products developed that they want to move forward on, but they can't go anywhere until the templates have been designed and the appropriate designators have been standardized and the approval process has been released.
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM